| Literature DB >> 34743491 |
Naresh Babu1, Jayant Kumar1, Piyush Kohli1, Ashish Ahuja1, Prerana Shah1, Kim Ramasamy1.
Abstract
PURPOSE: To evaluate the clinical presentation, management, and outcome of eyes with an inadvertent globe perforation during peribulbar or retrobulbar block.Entities:
Keywords: Local anesthesia; Perforation; Peribulbar block; Retinal detachment; Retinal perforations
Mesh:
Year: 2021 PMID: 34743491 PMCID: PMC8849991 DOI: 10.3341/kjo.2021.0090
Source DB: PubMed Journal: Korean J Ophthalmol ISSN: 1011-8942
Fig. 1Flowchart representing the number of patients who were treated for inadvertent ocular perforation during peribulbar and retrobulbar anesthesia. RRD = rhegmatogenous retinal detachment; VH = Vitreous hemorrhage; PVR = proliferative vitreoretinopathy changes.
Comparison of the time of recognition of the accidental globe perforation among the in-house and the patients referred from outside
| Variable | In-house perforation (n = 15) | Patients referred from outside (n = 10) |
|---|---|---|
| Planned surgery before which the perforation happened | ||
| Cataract surgery | 13 | 10 |
| Penetrating keratoplasty | 1 | - |
| Silicone oil removal | 1 | - |
| Perforation recognized at the time of block | 8 (53.3) | 1 (10.0) |
| Surgery postponed after the perforation was recognized | 1 | 1 |
| Perforation recognized on postoperative day 1 | 6 (40.0) | 8 (80.0) |
| Perforation recognized within the first month | 1 (6.7)[ | 1 (10.0) |
Values are presented as number or number (%); Only the patients who underwent treatment have been included.
Penetrating keratoplasty.
Fig. 2Bjerrum chart showing the location of all the perforation sites in each patient in their respective (A) right eye and (B) left eye (black circle, entry wound; red circle, exit wound).
Fig. 3Images of patient 14. Optical coherence tomography line scans at presentation through (A) the site of perforation and (B) fovea showing macular pucker. (C) Fundus image after silicone oil removal showing the site of perforation with a healthy macula. (D) Optical coherence tomography line scan after vitrectomy and silicone oil tamponade showing a settled macula with no epiretinal membrane. A written informed consent for publication of the clinical images was obtained from the patient.
Fig. 4Ultrawide field images (Optomap Panoramic 200 Standard imaging system; Optos, Dunfermline, UK) taken after silicone oil removal of (A) patient 15 showing lasered site of perforation in the inferotemporal quadrant and (B) patient 19 showing lasered breaks in the inferior half (original retinal detachment surgery) and lasered site of perforation in the superotemporal quadrant. Patient 19 had inadvertent perforation at the time of silicone oil removal. Written informed consents for publication of the clinical images were obtained from the patients.
Demographic and clinical feature of the patients who presented with a clear media (group 1)
| Patient no. | Age (yr) | Sex | Initial BCVA | Axial length | Complications | Management | Anatomical outcome | Final BCVA |
|---|---|---|---|---|---|---|---|---|
| 13 | 65 | Male | 20/20 | 24.15 | Retinal break, hypotony | Laser photocoagulation | Attached retina | 20/20 |
| 16 | 47 | Female | 20/60 | 23.56 | Retinal break, hypotony | Laser photocoagulation | Attached retina | 20/60 |
| 17 | 65 | Female | 20/200 | 23.09 | Retinal break, hypotony | Laser photocoagulation | Attached retina | 20/80 |
| 19 | 49 | Male | 20/300 | 23.89 | Retinal break, hypotony | Laser photocoagulation[ | Attached retina | 20/80 |
| 20 | 60 | Male | 20/120 | 23.84 | Retinal break, hypotony | Laser photocoagulation | Attached retina | 20/40 |
| 21 | 58 | Female | 20/40 | 23.24 | Retinal break, hypotony | Laser photocoagulation | Attached retina | 20/20 |
| 24 | 70 | Male | Finger counting | 22.93 | Retinal break, central retinal artery occlusion | Laser photocoagulation | Attached retina | Finger counting |
| 25 | 47 | Female | 20/60 | 23.47 | Retinal break, hypotony | Laser photocoagulation | Attached retina | 20/60 |
BCVA = best-corrected visual acuity.
Planned for silicone oil removal with drainage implant, underwent additional endolaser.
Demographic and clinical feature of the patients who presented with vitreous hemorrhage but no retinal detachment (group 2)
| Patient no. | Age (yr) | Sex | Initial BCVA | Axial length | Complications | Management | Anatomical outcome | Final BCVA |
|---|---|---|---|---|---|---|---|---|
| 1 | 65 | Male | Hand movement | 23.80 | Retinal break | Vitrectomy, endolaser, SO | Attached retina | 20/60 |
| 2 | 80 | Male | Perception of light+ | 24.06 | Retinal break, subretinal hemorrhage | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
| 4 | 60 | Male | 20/400 | 21.50 | Retinal break, subretinal hemorrhage | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
| 6 | 55 | Male | 20/200 | 29.37 | Retinal break | Vitrectomy, endolaser, SO | Attached retina | 20/40 |
| 7 | 60 | Female | Finger counting | 29.04 | Retinal break, FTMH | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
| 8 | 65 | Female | 20/1,200 | 23.68 | Retinal break, FTMH | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
| 9 | 55 | Male | Perception of light+ | 21.54 | Retinal break, central retinal vein occlusion | Vitrectomy, endolaser, SO | Attached retina | 20/80 |
| 14 | 50 | Male | 20/1,200 | 20.90 | Retinal break, macular pucker | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
| 15 | 75 | Male | 20/2,400 | 22.96 | Retinal break | Vitrectomy, endolaser, SF6 | Attached retina | 20/40 |
| 23 | 71 | Female | 20/800 | 22.77 | Retinal break | Vitrectomy, endolaser, SF6 | Attached retina | 20/60 |
BCVA = best-corrected visual acuity; FTMH = full-thickness macular hole; SO = silicone oil; SF6 = sulfur hexafluoride.
Demographic and clinical feature of the patients presented with rhegmatogenous retinal detachment with or without VH (group 3)
| Patient no. | Age (yr) | Sex | Initial BCVA | Axial length | Complications | Management | Anatomical outcome | Final BCVA |
|---|---|---|---|---|---|---|---|---|
| 3 | 60 | Female | Hand movement | 25.77 | VH, retinal break, subretinal hemorrhage, FTMH | Vitrectomy, endolaser, SO | Attached retina | 20/1,200 |
| 5 | 55 | Female | Perception of light+ | 26.89 | VH, retinal break, subretinal hemorrhage, FTMH | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
| 10 | 72 | Female | 20/400 | 24.30 | VH, retinal break, IT-BRAO | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
| 11 | 42 | Male | 20/200 | 31.22 | VH, Retinal break, hypotony | Vitrectomy, endolaser, SO | Attached retina | 20/120 |
| 12 | 46 | Male | Finger counting | 29.59 | VH, Retinal break, FTMH, retinal necrosis | Vitrectomy, endolaser, SO | Attached retina | 20/240 |
| 18 | 36 | Female | 20/1,200 | 24.18 | Retinal break | Vitrectomy, endolaser, SO | Attached retina | Finger counting |
| 22 | 71 | Female | Perception of light+ | 26.89 | Retinal break | Treatment not taken[ | Retinal detachment | Perception of ligh+ |
VH = vitreous hemorrhage; BCVA = best-corrected visual acuity; FTMH = full-thickness macular hole; SO = silicone oil; IT-BRAO = infero-temporal branch retinal artery occlusion.
Vitrectomy avoided because of advanced proliferative vitreoretinopathy changes and poor visual prognosis.
Comparison of baseline features and outcome among the three groups
| Variable | Group 1 | Group 2 | Group 3 | |
|---|---|---|---|---|
| No. of patients | 8 (32.0) | 10 (40.0) | 7 (28.0) | |
| Age (yr) | 57.6 ± 9.0 | 63.6 ± 9.5 | 54.6 ± 14.0 | 0.233[ |
| Sex (female : male) | 4 : 4 | 3 : 7 | 5 : 2 | 0.280 |
| Ocular laterality (right : left) | 3 : 5 | 7 : 3 | 4 : 3 | 0.366 |
| Axial length (mm) | 23.5 ± 0.4 | 24.0 ± 3.0 | 26.9 ± 2.6 | 0.021[ |
| No. of eyes where perforation was recognized at the time of anesthesia | 7 (87.5) | 0 (0.0) | 2 (28.6) | <0.001 |
| Clockwise location of perforation (inferior half : superior half) | 2 : 6 | 8 : 2 | 4 : 5 | 0.073 |
| No. of eyes with perforation inside the posterior pole | 0 (0.0) | 3 (30.0) | 2 (28.6) | 0.265 |
| No. of eyes with >1 perforations | 1 (12.5) | 5 (50.0) | 4 (57.1) | 0.159 |
| No. of eyes with vascular event | 1 (12.5) | 1 (10.0) | 2 (28.3) | 0.646 |
| Median initial BCVA | 0.009[ | |||
| logMAR | 0.63 | 1.78 | 2.30 | |
| Snellen equivalent | 20/85 | 20/1,205 | 20/3,991 | |
| Median final BCVA | 0.006[ | |||
| logMAR | 0.48 | 0.69 | 1.08 | |
| Snellen equivalent | 20/60 | 20/98 | 20/240 |
Values are presented as number (%), number, or mean ± standard deviation.
BCVA = best-corrected visual acuity; logMAR = logarithm of the minimum angle of resolution.
Fisher exact test;
ANOVA test;
Kruskal-Wallis test.
Summary of the previously published studies highlighting the management of inadvertent needle perforation during ocular local anesthesia (minimum ten cases)
| Study | Type of injection | Retinal detachment (%) | Management (%) | Anatomical outcome (%) | Visual outcome | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||||||
| Retro | Peri | Subconj | NA | Surgery | Laser/cryopexy | ≥20/40 | 20/50–20/200 | 19/200–3/200 | ≤Finger counting | |||
| Grizzard et al. [ | 5 | 4 | - | 3 | 41.7 | 41.7 | 41.7 | Attached, 75.0 Only peripheral detachment, 16.7 | 7 | 0 | 1 | 4 |
| Duker et al. [ | 18 | 2 | - | - | 55.5 | 80.0 | 0.0 | Attached, 75.0 | 3 | 3 | 1 | 13 |
| Hay et al. [ | 12 | 11 | - | - | 60.9 | 56.5 | 21.7 | Attached, 82.6 | 6 | 3 | 3 | 11 |
| Rinkoff et al. [ | 11 | - | - | 1 | 25.0 | 54.5 | 41.7 | Attached, 83.3 | 3 | 6 | 2 | 1 |
| McCombe et al. [ | 9 | 2 | - | 2 | 30.8 | 69.2 | NA | Attached, 92.3 | 6 | 4[ | - | 11 |
| Wearne et al. [ | 14 | 4 | - | 2 | 50.0 | 85.0 | 5.0 | Attached, 55.0 | 7 | 5 | 0 | 8 |
| Gadkari et al. [ | 6 | 10 | 3 | - | 42.1 | 73.7 | 21.1 | Attached, 94.7 | 7 | 7 | 2 | 3 |
| Current series | - | 15 | - | 10 | 28.0 | 68.0 | 28.0 | Attached, 96.0 | 5 | 15 | 2 | 3 |
Values are presented as number.
Retro = retroocular anesthesia; Peri = peribulbar anesthesia; Subconj = subconjunctival anesthesia; NA = not available.
20/60–20/80.